<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:sdc="http://www.alacra.com/sdc" xmlns:bir="http://www.alacra.com/bir" xmlns:ccbn="http://www.alacra.com/ccbn" xmlns:srp="http://www.alacra.com/srp" xmlns:newstex="http://www.alacra.com/newstex" ><channel><title>Synovis Life Technologies, Inc. RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>Synovis Life Technologies, Inc.</description>
<link>http://www.alacrastore.com/company-snapshot/Synovis_Life_Technologies_Inc-1002150</link>
<lastBuildDate>Sunday, October 12, 2008 5:16:32 AM</lastBuildDate>
<alacra:xlsid>1002150</alacra:xlsid>
<alacra:company>Synovis Life Technologies, Inc.</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><link>http://www.alacrastore.com/storecontent/bir/322547</link><guid isPermaLink="false">bir/322547</guid><bir:index_mode xmlns:bir="http://www.alacra.com/bir">norm</bir:index_mode><title>Synovis Life Technologies Inc.</title><bir:company xmlns:bir="http://www.alacra.com/bir">Synovis Life Technologies Inc.</bir:company><bir:company xmlns:bir="http://www.alacra.com/bir">Bio-Vascular Inc.</bir:company><bir:cou xmlns:bir="http://www.alacra.com/bir">United States</bir:cou><bir:descr xmlns:bir="http://www.alacra.com/bir">Manufacturing: Medical devices used primarily for cardiac and vascular surgery.</bir:descr><bir:sic xmlns:bir="http://www.alacra.com/bir">3842</bir:sic><bir:naics xmlns:bir="http://www.alacra.com/bir">339113</bir:naics><bir:class xmlns:bir="http://www.alacra.com/bir">17</bir:class><bir:size xmlns:bir="http://www.alacra.com/bir">D</bir:size><bir:revenue xmlns:bir="http://www.alacra.com/bir">G</bir:revenue><bir:ticker xmlns:bir="http://www.alacra.com/bir">SYNO</bir:ticker><pubDate>8/28/2008 6:14:47 AM</pubDate><bir:docid xmlns:bir="http://www.alacra.com/bir">322547</bir:docid><category>Company Profiles &amp; Financials</category><alacra:ip>Gale Company Profiles</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1923100</link><guid isPermaLink="false">ccbn/T1923100</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good day, ladies and gentlemen and welcome to the third-quarter #### Synovis Life Technologies Inc. earnings conference call. My name is Ahmad and I will be your coordinator for today. At this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session towards the end of this conference. (Operator Instructions). As a reminder, this conference is being recorded for replay purposes. I would now like to turn the presentation over to your host for today's call, Mr. Richard Kramp, President and Chief Executive Officer of Synovis. Please proceed. ...

</description><pubDate>8/27/2008 1:04:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Synovis Life Technologies, Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Synovis Life Technologies, Inc. Q3 2008 Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYNO</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">10:00am CT</ccbn:time><title>Synovis Life Technologies, Inc. Q3 2008 Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1923100</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/BW-0001-27376862</link><guid isPermaLink="false">newstex/BW-0001-27376862</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> Aug. ##, #### (Business Wire) --  Synovis Life Technologies, Inc., (NASDAQ: SYNO) will host a live Webcast of its fiscal third-quarter conference call on Wednesday, Aug. ##, ####, at ## a.m. CT. Synovis President and Chief Executive...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><pubDate>8/13/2008 10:21:57 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">Business Wire</newstex:Publication><title>Synovis Life Technologies to Webcast Fiscal Third-Quarter Earnings Conference Call Wednesday, August 27</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">BW-0001-27376862</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">ICON PLC</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">SYNOVIS LIFE TECHNOLOGIES INC</newstex:index_entry_company><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">BRETT REYNOLDS</newstex:index_entry_person><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">RICHARD W KRAMP</newstex:index_entry_person><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">ICLR</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">SYNO</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><title>Synovis LIfe technologies Inc buys back stock</title><description>US - In May ####, the board of Synovis Life Technologies Inc (SL), a manufacturer of cardiovascular products, authorized the repurchase of up to # mil common shares, or about #.##% of the company's common stock outstanding, in open market or privately negotiated transactions. Based on SL's closing stock price of $##.## on May ##, the last full trading day prior to the announcement of the board's approval, the buyback had an indicated value of $##.## mil in cash.</description><pubDate>5/30/2008 5:21:34 PM</pubDate><sdc:company_cusip xmlns:sdc="http://www.alacra.com/sdc">87162G</sdc:company_cusip><sdc:target_company_cusip xmlns:sdc="http://www.alacra.com/sdc">87162G</sdc:target_company_cusip><sdc:company_cusip_up xmlns:sdc="http://www.alacra.com/sdc">87162G</sdc:company_cusip_up><sdc:target_company_cusip_up xmlns:sdc="http://www.alacra.com/sdc">87162G</sdc:target_company_cusip_up><sdc:company xmlns:sdc="http://www.alacra.com/sdc">Synovis Life Technologies Inc</sdc:company><sdc:target_company xmlns:sdc="http://www.alacra.com/sdc">Synovis Life Technologies Inc</sdc:target_company><sdc:company_up xmlns:sdc="http://www.alacra.com/sdc">Synovis Life Technologies Inc</sdc:company_up><sdc:target_company_up xmlns:sdc="http://www.alacra.com/sdc">Synovis Life Technologies Inc</sdc:target_company_up><link>http://www.alacrastore.com/storecontent/Thomson_M%26A/Synovis_LIfe_technologies_Inc_buys_back_stock-1981963020</link><guid isPermaLink="false">sdc/1981963020</guid><sdc:deal xmlns:sdc="http://www.alacra.com/sdc"><sdc:deal_no>1981963020</sdc:deal_no><sdc:_copyright><sdc:value>Copyright Â© 2008, Thomson Financial, All Rights Reserved</sdc:value></sdc:_copyright><sdc:a_EXCHANGE><sdc:value>Nasdaq</sdc:value></sdc:a_EXCHANGE><sdc:a_MAINDUSTRY><sdc:value>Measuring, Medical, Photo Equipment; Clocks</sdc:value></sdc:a_MAINDUSTRY><sdc:a_NATION><sdc:value>United States</sdc:value></sdc:a_NATION><sdc:a_SICDESC><sdc:value>Orthopedic, prosthetic, and surgical supplies</sdc:value></sdc:a_SICDESC><sdc:a_SICPI><sdc:value>3842</sdc:value></sdc:a_SICPI><sdc:a_STATE><sdc:value>MN</sdc:value></sdc:a_STATE><sdc:a_STATELONG><sdc:value>Minnesota</sdc:value></sdc:a_STATELONG><sdc:a_STATUS><sdc:value>Public</sdc:value></sdc:a_STATUS><sdc:a_TICKER><sdc:value>SYNO</sdc:value></sdc:a_TICKER><sdc:asic_SIC><sdc:value sdc:p="0">3842:Orthopedic, prosthetic, and surgical supplies</sdc:value><sdc:value sdc:p="1">5047:Medical, dental, and hospital equipment &amp; supplies</sdc:value></sdc:asic_SIC><sdc:aupsic_SIC><sdc:value sdc:p="0">3842:Orthopedic, prosthetic, and surgical supplies</sdc:value><sdc:value sdc:p="1">5047:Medical, dental, and hospital equipment &amp; supplies</sdc:value></sdc:aupsic_SIC><sdc:b_EXCHANGE><sdc:value>Nasdaq</sdc:value></sdc:b_EXCHANGE><sdc:b_MAINDUSTRY><sdc:value>Measuring, Medical, Photo Equipment; Clocks</sdc:value></sdc:b_MAINDUSTRY><sdc:b_NATION><sdc:value>United States</sdc:value></sdc:b_NATION><sdc:b_SICDESC><sdc:value>Orthopedic, prosthetic, and surgical supplies</sdc:value></sdc:b_SICDESC><sdc:b_SICPI><sdc:value>3842</sdc:value></sdc:b_SICPI><sdc:b_STATE><sdc:value>MN</sdc:value></sdc:b_STATE><sdc:b_STATELONG><sdc:value>Minnesota</sdc:value></sdc:b_STATELONG><sdc:b_STATUS><sdc:value>Public</sdc:value></sdc:b_STATUS><sdc:b_TICKER><sdc:value>SYNO</sdc:value></sdc:b_TICKER><sdc:c_ACIDGEN><sdc:value>21996003</sdc:value></sdc:c_ACIDGEN><sdc:c2up_BUSS><sdc:value>Mnfr cardio-vascular prod</sdc:value></sdc:c2up_BUSS><sdc:c3up_BUSS><sdc:value>Mnfr cardio-vascular prod</sdc:value></sdc:c3up_BUSS><sdc:co_DESCR><sdc:value sdc:p="0">Cash</sdc:value><sdc:value sdc:p="1">Cash Only</sdc:value></sdc:co_DESCR><sdc:cs_DESCR><sdc:value>Common Stock</sdc:value></sdc:cs_DESCR><sdc:d_TCIDGEN><sdc:value>21996003</sdc:value></sdc:d_TCIDGEN><sdc:date_lastupdate><sdc:value>May 30 2008</sdc:value></sdc:date_lastupdate><sdc:finbltm_BV><sdc:value>0.00000</sdc:value></sdc:finbltm_BV><sdc:finbltm_CASH><sdc:value>0.00000</sdc:value></sdc:finbltm_CASH><sdc:finbltm_CASHFLOW><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW><sdc:finbltm_CASHFLOW1><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW1><sdc:finbltm_CASHFLOW2><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW2><sdc:finbltm_CASHFLOW3><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW3><sdc:finbltm_CASHFLOW4><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW4><sdc:finbltm_CASHFLOW5><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW5><sdc:finbltm_COMEQ><sdc:value>0.00000</sdc:value></sdc:finbltm_COMEQ><sdc:finbltm_DEBTRAT><sdc:value>0.00000</sdc:value></sdc:finbltm_DEBTRAT><sdc:finbltm_DSER2><sdc:value>0.00000</sdc:value></sdc:finbltm_DSER2><sdc:finbltm_EBIT><sdc:value>0.00000</sdc:value></sdc:finbltm_EBIT><sdc:finbltm_EPS><sdc:value>0.00000</sdc:value></sdc:finbltm_EPS><sdc:finbltm_NI><sdc:value>0.00000</sdc:value></sdc:finbltm_NI><sdc:finbltm_PTINC><sdc:value>0.00000</sdc:value></sdc:finbltm_PTINC><sdc:finbltm_SALES><sdc:value>0.00000</sdc:value></sdc:finbltm_SALES><sdc:finbltm_STDEBT><sdc:value>0.00000</sdc:value></sdc:finbltm_STDEBT><sdc:finbltm_TASS><sdc:value>0.00000</sdc:value></sdc:finbltm_TASS><sdc:fiscal_ADCR><sdc:value>0.00000</sdc:value></sdc:fiscal_ADCR><sdc:fiscal_AEPS><sdc:value>0.00000</sdc:value></sdc:fiscal_AEPS><sdc:fiscal_ANI><sdc:value>0.00000</sdc:value></sdc:fiscal_ANI><sdc:fiscal_APFDCR><sdc:value>0.00000</sdc:value></sdc:fiscal_APFDCR><sdc:fiscal_ASALES><sdc:value>0.00000</sdc:value></sdc:fiscal_ASALES><sdc:fiscal_ATASS><sdc:value>0.00000</sdc:value></sdc:fiscal_ATASS><sdc:fiscal_RATE><sdc:value>0.00000</sdc:value></sdc:fiscal_RATE><sdc:g_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value><sdc:value sdc:p="8">9.00000</sdc:value><sdc:value sdc:p="9">10.00000</sdc:value><sdc:value sdc:p="10">11.00000</sdc:value><sdc:value sdc:p="11">12.00000</sdc:value></sdc:g_SEQ><sdc:g_TEST><sdc:value sdc:p="0">Synovis Life Technologies Inc,</sdc:value><sdc:value sdc:p="1">located in St Paul, Minnesota,</sdc:value><sdc:value sdc:p="2">manufactures and wholesales</sdc:value><sdc:value sdc:p="3">specialty medical products</sdc:value><sdc:value sdc:p="4">used in thoracic, cardiac,</sdc:value><sdc:value sdc:p="5">neuro and vascular surgery</sdc:value><sdc:value sdc:p="6">including Tissue-Guard product</sdc:value><sdc:value sdc:p="7">line and Biograft peripheral</sdc:value><sdc:value sdc:p="8">vascular graft; wholesale</sdc:value><sdc:value sdc:p="9">surgical tools used in cardiac</sdc:value><sdc:value sdc:p="10">and vascular surgery. The</sdc:value><sdc:value sdc:p="11">company was founded in 1985.</sdc:value></sdc:g_TEST><sdc:g_business><sdc:value sdc:p="0">Synovis Life Technologies Inc, located in St Paul,</sdc:value><sdc:value sdc:p="1">Minnesota, manufactures and wholesales specialty medical</sdc:value><sdc:value sdc:p="2">products used in thoracic, cardiac, neuro and vascular</sdc:value><sdc:value sdc:p="3">surgery including Tissue-Guard product line and Biograft</sdc:value><sdc:value sdc:p="4">peripheral vascular graft; wholesale surgical tools used in</sdc:value><sdc:value sdc:p="5">cardiac and vascular surgery. The company was founded in</sdc:value><sdc:value sdc:p="6">1985.</sdc:value></sdc:g_business><sdc:g_business1><sdc:value>Synovis Life Technologies Inc, located in St Paul, Minnesota, manufactures and wholesales specialty medical products used in thoracic, cardiac, neuro and vascular surgery including Tissue-Guard product line and Biograft peripheral vascular graft; wholesale surgical tools used in cardiac and vascular surgery. The company was founded in 1985.</sdc:value></sdc:g_business1><sdc:h_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value><sdc:value sdc:p="8">9.00000</sdc:value><sdc:value sdc:p="9">10.00000</sdc:value><sdc:value sdc:p="10">11.00000</sdc:value><sdc:value sdc:p="11">12.00000</sdc:value></sdc:h_SEQ><sdc:h_TEST><sdc:value sdc:p="0">Synovis Life Technologies Inc,</sdc:value><sdc:value sdc:p="1">located in St Paul, Minnesota,</sdc:value><sdc:value sdc:p="2">manufactures and wholesales</sdc:value><sdc:value sdc:p="3">specialty medical products</sdc:value><sdc:value sdc:p="4">used in thoracic, cardiac,</sdc:value><sdc:value sdc:p="5">neuro and vascular surgery</sdc:value><sdc:value sdc:p="6">including Tissue-Guard product</sdc:value><sdc:value sdc:p="7">line and Biograft peripheral</sdc:value><sdc:value sdc:p="8">vascular graft; wholesale</sdc:value><sdc:value sdc:p="9">surgical tools used in cardiac</sdc:value><sdc:value sdc:p="10">and vascular surgery. The</sdc:value><sdc:value sdc:p="11">company was founded in 1985.</sdc:value></sdc:h_TEST><sdc:h_business><sdc:value sdc:p="0">Synovis Life Technologies Inc, located in St Paul,</sdc:value><sdc:value sdc:p="1">Minnesota, manufactures and wholesales specialty medical</sdc:value><sdc:value sdc:p="2">products used in thoracic, cardiac, neuro and vascular</sdc:value><sdc:value sdc:p="3">surgery including Tissue-Guard product line and Biograft</sdc:value><sdc:value sdc:p="4">peripheral vascular graft; wholesale surgical tools used in</sdc:value><sdc:value sdc:p="5">cardiac and vascular surgery. The company was founded in</sdc:value><sdc:value sdc:p="6">1985.</sdc:value></sdc:h_business><sdc:h_business1><sdc:value>Synovis Life Technologies Inc, located in St Paul, Minnesota, manufactures and wholesales specialty medical products used in thoracic, cardiac, neuro and vascular surgery including Tissue-Guard product line and Biograft peripheral vascular graft; wholesale surgical tools used in cardiac and vascular surgery. The company was founded in 1985.</sdc:value></sdc:h_business1><sdc:i_AFEEPCT><sdc:value>0.00000</sdc:value></sdc:i_AFEEPCT><sdc:i_AFEETOT><sdc:value>0.00000</sdc:value></sdc:i_AFEETOT><sdc:i_ATERMFEE><sdc:value>0.00000</sdc:value></sdc:i_ATERMFEE><sdc:i_COMOUT><sdc:value>12.39000</sdc:value></sdc:i_COMOUT><sdc:i_CROSS1><sdc:value>N</sdc:value></sdc:i_CROSS1><sdc:i_CURRENCYLONG><sdc:value>U.S. Dollar</sdc:value></sdc:i_CURRENCYLONG><sdc:i_DATEANN><sdc:value>28 May 08</sdc:value></sdc:i_DATEANN><sdc:i_DATEANN2><sdc:value>Wed, 28 May 2008 00:00:00 EST</sdc:value></sdc:i_DATEANN2><sdc:i_DATEANNS><sdc:value>Date Announced: 05/28/2008</sdc:value></sdc:i_DATEANNS><sdc:i_DATEEFFS><sdc:value>Date Effective:</sdc:value></sdc:i_DATEEFFS><sdc:i_DESCR><sdc:value>Buyback</sdc:value></sdc:i_DESCR><sdc:i_DESCR1><sdc:value>Not Appl.</sdc:value></sdc:i_DESCR1><sdc:i_FEEPCT><sdc:value>0.00000</sdc:value></sdc:i_FEEPCT><sdc:i_FEETOT><sdc:value>0.00000</sdc:value></sdc:i_FEETOT><sdc:i_HOSTAFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTAFEETOT><sdc:i_HOSTENTVAL><sdc:value>0.00000</sdc:value></sdc:i_HOSTENTVAL><sdc:i_HOSTFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTFEETOT><sdc:i_HOSTPR><sdc:value>18.26000</sdc:value></sdc:i_HOSTPR><sdc:i_HOSTPRLABEL><sdc:value>Price/Share</sdc:value></sdc:i_HOSTPRLABEL><sdc:i_HOSTTFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTTFEETOT><sdc:i_HOSTVALUE><sdc:value>18.26 U.S. Dollar</sdc:value></sdc:i_HOSTVALUE><sdc:i_HOSTVALUE1><sdc:value>18.26000</sdc:value></sdc:i_HOSTVALUE1><sdc:i_HOST_EQVAL><sdc:value>226.29600</sdc:value></sdc:i_HOST_EQVAL><sdc:i_HOST_RANKVAL><sdc:value>18.26 U.S. Dollar</sdc:value></sdc:i_HOST_RANKVAL><sdc:i_HOST_RANKVAL1><sdc:value>18.26000</sdc:value></sdc:i_HOST_RANKVAL1><sdc:i_PCTACQ><sdc:value>0.00000</sdc:value></sdc:i_PCTACQ><sdc:i_PCTOWN><sdc:value>0.00000</sdc:value></sdc:i_PCTOWN><sdc:i_PR><sdc:value>18.26000</sdc:value></sdc:i_PR><sdc:i_PR_INITIAL><sdc:value>18.26000</sdc:value></sdc:i_PR_INITIAL><sdc:i_RANKVAL><sdc:value>18.26000</sdc:value></sdc:i_RANKVAL><sdc:i_RANK_HOSTRANKVAL><sdc:value>18.26 U.S. Dollar</sdc:value></sdc:i_RANK_HOSTRANKVAL><sdc:i_RATE><sdc:value>1.00000</sdc:value></sdc:i_RATE><sdc:i_STATUS_MMC><sdc:value>N</sdc:value></sdc:i_STATUS_MMC><sdc:i_STGVAL><sdc:value>9.22100</sdc:value></sdc:i_STGVAL><sdc:i_TERMFEE><sdc:value>0.00000</sdc:value></sdc:i_TERMFEE><sdc:i_TFEEPCT><sdc:value>0.00000</sdc:value></sdc:i_TFEEPCT><sdc:i_TFEETOT><sdc:value>0.00000</sdc:value></sdc:i_TFEETOT><sdc:i_TTERMFEE><sdc:value>0.00000</sdc:value></sdc:i_TTERMFEE><sdc:i_VALLIA><sdc:value>0.00000</sdc:value></sdc:i_VALLIA><sdc:i_VALNOLIA><sdc:value>18.26000</sdc:value></sdc:i_VALNOLIA><sdc:i_VALUE><sdc:value>18.26000</sdc:value></sdc:i_VALUE><sdc:j_EQVALCF><sdc:value>0.00000</sdc:value></sdc:j_EQVALCF><sdc:j_EVCF><sdc:value>0.00000</sdc:value></sdc:j_EVCF><sdc:j_EVEBIT><sdc:value>0.00000</sdc:value></sdc:j_EVEBIT><sdc:j_EVNI><sdc:value>0.00000</sdc:value></sdc:j_EVNI><sdc:j_EVSALES><sdc:value>0.00000</sdc:value></sdc:j_EVSALES><sdc:j_MPRICEBOOK><sdc:value>0.00000</sdc:value></sdc:j_MPRICEBOOK><sdc:j_PHELD><sdc:value>0.00000</sdc:value></sdc:j_PHELD><sdc:j_PSOUGHT><sdc:value>8.06900</sdc:value></sdc:j_PSOUGHT><sdc:j_RANKVALCF><sdc:value>0.00000</sdc:value></sdc:j_RANKVALCF><sdc:j_RANKVALEB><sdc:value>0.00000</sdc:value></sdc:j_RANKVALEB><sdc:j_RANKVALNA><sdc:value>0.00000</sdc:value></sdc:j_RANKVALNA><sdc:j_RANKVALNI><sdc:value>0.00000</sdc:value></sdc:j_RANKVALNI><sdc:j_RANKVALSALES><sdc:value>0.00000</sdc:value></sdc:j_RANKVALSALES><sdc:j_VALEB><sdc:value>0.00000</sdc:value></sdc:j_VALEB><sdc:j_VALNI><sdc:value>0.00000</sdc:value></sdc:j_VALNI><sdc:j_VALSALES><sdc:value>0.00000</sdc:value></sdc:j_VALSALES><sdc:m_AMV><sdc:value>0.00000</sdc:value></sdc:m_AMV><sdc:m_CF3YGR><sdc:value>0.00000</sdc:value></sdc:m_CF3YGR><sdc:m_CF5YGR><sdc:value>0.00000</sdc:value></sdc:m_CF5YGR><sdc:m_DCR><sdc:value>0.00000</sdc:value></sdc:m_DCR><sdc:m_ENTVAL><sdc:value>0.00000</sdc:value></sdc:m_ENTVAL><sdc:m_EPS3YGR><sdc:value>0.00000</sdc:value></sdc:m_EPS3YGR><sdc:m_EPS5YGR><sdc:value>0.00000</sdc:value></sdc:m_EPS5YGR><sdc:m_LTD><sdc:value>0.00000</sdc:value></sdc:m_LTD><sdc:m_MV><sdc:value>0.00000</sdc:value></sdc:m_MV><sdc:m_NETASS><sdc:value>0.00000</sdc:value></sdc:m_NETASS><sdc:m_NETASS3YGR><sdc:value>0.00000</sdc:value></sdc:m_NETASS3YGR><sdc:m_NETASS5YGR><sdc:value>0.00000</sdc:value></sdc:m_NETASS5YGR><sdc:m_NI3YGR><sdc:value>0.00000</sdc:value></sdc:m_NI3YGR><sdc:m_NI5YGR><sdc:value>0.00000</sdc:value></sdc:m_NI5YGR><sdc:n_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value><sdc:value sdc:p="8">9.00000</sdc:value><sdc:value sdc:p="9">10.00000</sdc:value><sdc:value sdc:p="10">11.00000</sdc:value><sdc:value sdc:p="11">12.00000</sdc:value><sdc:value sdc:p="12">13.00000</sdc:value><sdc:value sdc:p="13">14.00000</sdc:value><sdc:value sdc:p="14">15.00000</sdc:value><sdc:value sdc:p="15">16.00000</sdc:value><sdc:value sdc:p="16">17.00000</sdc:value></sdc:n_SEQ><sdc:n_SYNOPSIS><sdc:value sdc:p="0">US - In May 2008, the board of</sdc:value><sdc:value sdc:p="1">Synovis Life Technologies Inc</sdc:value><sdc:value sdc:p="2">(SL), a manufacturer of</sdc:value><sdc:value sdc:p="3">cardiovascular products,</sdc:value><sdc:value sdc:p="4">authorized the repurchase of</sdc:value><sdc:value sdc:p="5">up to 1 mil common shares, or</sdc:value><sdc:value sdc:p="6">about 8.07% of the company's</sdc:value><sdc:value sdc:p="7">common stock outstanding, in</sdc:value><sdc:value sdc:p="8">open market or privately</sdc:value><sdc:value sdc:p="9">negotiated transactions. Based</sdc:value><sdc:value sdc:p="10">on SL's closing stock price of</sdc:value><sdc:value sdc:p="11">$18.26 on May 27, the last</sdc:value><sdc:value sdc:p="12">full trading day prior to the</sdc:value><sdc:value sdc:p="13">announcement of the board's</sdc:value><sdc:value sdc:p="14">approval, the buyback had an</sdc:value><sdc:value sdc:p="15">indicated value of $18.26 mil</sdc:value><sdc:value sdc:p="16">in cash.</sdc:value></sdc:n_SYNOPSIS><sdc:n_synopsis2><sdc:value>US - In May 2008, the board of Synovis Life Technologies Inc (SL), a manufacturer of cardiovascular products, authorized the repurchase of up to 1 mil common shares, or about 8.07% of the company's common stock outstanding, in open market or privately negotiated transactions. Based on SL's closing stock price of $18.26 on May 27, the last full trading day prior to the announcement of the board's approval, the buyback had an indicated value of $18.26 mil in cash.</sdc:value></sdc:n_synopsis2><sdc:n_synopsis3><sdc:value sdc:p="0">US - In May 2008, the board of Synovis Life Technologies Inc (SL), a manufacturer of</sdc:value><sdc:value sdc:p="1">cardiovascular products, authorized the repurchase of up to 1 mil common shares, or about</sdc:value><sdc:value sdc:p="2">8.07% of the company's common stock outstanding, in open market or privately negotiated</sdc:value><sdc:value sdc:p="3">transactions. Based on SL's closing stock price of $18.26 on May 27, the last full trading</sdc:value><sdc:value sdc:p="4">day prior to the announcement of the board's approval, the buyback had an indicated value</sdc:value><sdc:value sdc:p="5">of $18.26 mil in cash.</sdc:value></sdc:n_synopsis3><sdc:n_synopsis4><sdc:value sdc:p="0">US - In May 2008, the board of Synovis Life Technologies Inc (SL), a manufacturer of cardiovascular products, authorized the repurchase of up to 1 mil common shares, or about 8.07% of the company's</sdc:value><sdc:value sdc:p="1">common stock outstanding, in open market or privately negotiated transactions. Based on SL's closing stock price of $18.26 on May 27, the last full trading day prior to the announcement of the board's</sdc:value><sdc:value sdc:p="2">approval, the buyback had an indicated value of $18.26 mil in cash.</sdc:value></sdc:n_synopsis4><sdc:n_synopsis5><sdc:value sdc:p="0">US - In May 2008, the board of Synovis Life Technologies Inc (SL), a manufacturer of cardiovascular products, authorized the repurchase</sdc:value><sdc:value sdc:p="1">of up to 1 mil common shares, or about 8.07% of the company's common stock outstanding, in open market or privately negotiated</sdc:value><sdc:value sdc:p="2">transactions. Based on SL's closing stock price of $18.26 on May 27, the last full trading day prior to the announcement of the board's</sdc:value><sdc:value sdc:p="3">approval, the buyback had an indicated value of $18.26 mil in cash.</sdc:value></sdc:n_synopsis5><sdc:q_DESCR><sdc:value>Intended</sdc:value></sdc:q_DESCR><sdc:q_HOSTANETASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTANETASS><sdc:q_HOSTANILTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTANILTM><sdc:q_HOSTASALESLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTASALESLTM><sdc:q_HOSTATASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTATASS><sdc:q_HOSTBOOKVALUE><sdc:value>0.00000</sdc:value></sdc:q_HOSTBOOKVALUE><sdc:q_HOSTCASHFLOW><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW><sdc:q_HOSTCASHFLOW1><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW1><sdc:q_HOSTCASHFLOW2><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW2><sdc:q_HOSTCASHFLOW3><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW3><sdc:q_HOSTCASHFLOW4><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW4><sdc:q_HOSTCASHFLOW5><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW5><sdc:q_HOSTCOMMONEQUITY><sdc:value>0.00000</sdc:value></sdc:q_HOSTCOMMONEQUITY><sdc:q_HOSTEBITLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTEBITLTM><sdc:q_HOSTEPS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS1><sdc:q_HOSTEPS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS2><sdc:q_HOSTEPS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS3><sdc:q_HOSTEPS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS4><sdc:q_HOSTEPS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS5><sdc:q_HOSTEPSLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPSLTM><sdc:q_HOSTNETASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS><sdc:q_HOSTNETASS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS1><sdc:q_HOSTNETASS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS2><sdc:q_HOSTNETASS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS3><sdc:q_HOSTNETASS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS4><sdc:q_HOSTNETASS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS5><sdc:q_HOSTNI1><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI1><sdc:q_HOSTNI2><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI2><sdc:q_HOSTNI3><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI3><sdc:q_HOSTNI4><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI4><sdc:q_HOSTNI5><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI5><sdc:q_HOSTNILTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTNILTM><sdc:q_HOSTPTINC1><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC1><sdc:q_HOSTPTINC2><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC2><sdc:q_HOSTPTINC3><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC3><sdc:q_HOSTPTINC4><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC4><sdc:q_HOSTPTINC5><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC5><sdc:q_HOSTPTINCLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINCLTM><sdc:q_HOSTSALES1><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES1><sdc:q_HOSTSALES2><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES2><sdc:q_HOSTSALES3><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES3><sdc:q_HOSTSALES4><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES4><sdc:q_HOSTSALES5><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES5><sdc:q_HOSTSALESLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALESLTM><sdc:q_HOSTTASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS><sdc:q_HOSTTASS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS1><sdc:q_HOSTTASS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS2><sdc:q_HOSTTASS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS3><sdc:q_HOSTTASS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS4><sdc:q_HOSTTASS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS5><sdc:q_STATUS><sdc:value>Status:Intended</sdc:value></sdc:q_STATUS><sdc:r_PE><sdc:value>-999.00000</sdc:value></sdc:r_PE><sdc:r_PE_PRINT><sdc:value>np</sdc:value></sdc:r_PE_PRINT><sdc:r_PFTMARG><sdc:value>0.00000</sdc:value></sdc:r_PFTMARG><sdc:r_PRICEBOOK><sdc:value>-999.00000</sdc:value></sdc:r_PRICEBOOK><sdc:r_PRICEBOOK_PRINT><sdc:value>np</sdc:value></sdc:r_PRICEBOOK_PRINT><sdc:r_PTINC3YGR><sdc:value>0.00000</sdc:value></sdc:r_PTINC3YGR><sdc:r_PTINC5YGR><sdc:value>0.00000</sdc:value></sdc:r_PTINC5YGR><sdc:r_ROE><sdc:value>0.00000</sdc:value></sdc:r_ROE><sdc:r_SALES3YGR><sdc:value>0.00000</sdc:value></sdc:r_SALES3YGR><sdc:r_SALES5YGR><sdc:value>0.00000</sdc:value></sdc:r_SALES5YGR><sdc:r_SE><sdc:value>0.00000</sdc:value></sdc:r_SE><sdc:r_TASS3YGR><sdc:value>0.00000</sdc:value></sdc:r_TASS3YGR><sdc:r_TASS5YGR><sdc:value>0.00000</sdc:value></sdc:r_TASS5YGR><sdc:r_TTCFMULT><sdc:value>0.00000</sdc:value></sdc:r_TTCFMULT><sdc:r_TTEBITMULT><sdc:value>0.00000</sdc:value></sdc:r_TTEBITMULT><sdc:r_VALNA><sdc:value>0.00000</sdc:value></sdc:r_VALNA><sdc:sic_SIC><sdc:value sdc:p="0">3842:Orthopedic, prosthetic, and surgical supplies</sdc:value><sdc:value sdc:p="1">5047:Medical, dental, and hospital equipment &amp; supplies</sdc:value></sdc:sic_SIC><sdc:upa_UPACIDGEN><sdc:value>21996003</sdc:value></sdc:upa_UPACIDGEN><sdc:upa1_EXCHANGE><sdc:value>Nasdaq</sdc:value></sdc:upa1_EXCHANGE><sdc:upa1_NATION><sdc:value>United States</sdc:value></sdc:upa1_NATION><sdc:upa1_SICP><sdc:value>3842</sdc:value></sdc:upa1_SICP><sdc:upa1_STATE><sdc:value>Minnesota</sdc:value></sdc:upa1_STATE><sdc:upa1_STATUS><sdc:value>Public</sdc:value></sdc:upa1_STATUS><sdc:upa1_TICKER><sdc:value>SYNO</sdc:value></sdc:upa1_TICKER><sdc:upsic_SIC><sdc:value sdc:p="0">3842:Orthopedic, prosthetic, and surgical supplies</sdc:value><sdc:value sdc:p="1">5047:Medical, dental, and hospital equipment &amp; supplies</sdc:value></sdc:upsic_SIC><sdc:upt_UPTCIDGEN><sdc:value>21996003</sdc:value></sdc:upt_UPTCIDGEN><sdc:upt1_EXCHANGE><sdc:value>Nasdaq</sdc:value></sdc:upt1_EXCHANGE><sdc:upt1_NATION><sdc:value>United States</sdc:value></sdc:upt1_NATION><sdc:upt1_SICP><sdc:value>3842</sdc:value></sdc:upt1_SICP><sdc:upt1_STATE><sdc:value>Minnesota</sdc:value></sdc:upt1_STATE><sdc:upt1_STATUS><sdc:value>Public</sdc:value></sdc:upt1_STATUS><sdc:upt1_TICKER><sdc:value>SYNO</sdc:value></sdc:upt1_TICKER><sdc:x_RANK1_VALUE><sdc:value>18.26000</sdc:value></sdc:x_RANK1_VALUE><sdc:x_RANK_HOSTRANKVAL><sdc:value>18.26000</sdc:value></sdc:x_RANK_HOSTRANKVAL><sdc:x_RANK_RANKVAL><sdc:value>18.26000</sdc:value></sdc:x_RANK_RANKVAL><sdc:x_rank_rankstgval><sdc:value>9.22100</sdc:value></sdc:x_rank_rankstgval></sdc:deal><category>Deal Information</category><alacra:ip>TF Mergers &amp; Acquisitions</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1841527</link><guid isPermaLink="false">ccbn/T1841527</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good day, ladies and gentlemen, and welcome to the second quarter #### Synovis Life Technology, Incorporated earnings conference call. My name is Jasmine and I'll be the operator for today. At this time, all attendees are in a listen-only mode. We will conduct a question and answer session towards the end of this conference. (OPERATOR INSTRUCTIONS) I would now like to turn this presentation over to your host for today's call, Mr. Richard Kramp, Synovis' CEO and President. You may proceed, sir....

</description><pubDate>5/28/2008 12:20:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Synovis Life Technologies, Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q2 2008 Synovis Life Technologies, Inc. Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYNO</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">10:00am CT</ccbn:time><title>Q2 2008 Synovis Life Technologies, Inc. Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1841527</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1785168</link><guid isPermaLink="false">ccbn/T1785168</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>... - Synovis Life Technologies, Inc. -  ChairmanGood afternoon. The annual meeting of the shareholders of Synovis Life Technologies is hereby called to order. I'm Timothy  Scanlan, Chairman of the board of the Company. And I'll act as Chairman of this meeting. Seated at the podium with me are Mr. Rich Kramp, President, Chief Executive Officer, and Director of the Company, will act as Secretary of the meeting; and Michael Kolar, attorney with Oppenheimer Wolff Donnelly, legal counsel to the Company, and will serve as Inspector of Elections. I'd like to introduce the directors of the Company and ask them to stand. In addition to Richard Kramp and myself, all of our directors are present. They are Bill Kobi, Karen Larson, Mark Palma, Dick Perkins, John Seaberg and Sven Wehrwein. At this time, I'd like to introduce other officers of the Company who are present at the meeting and ask them to stand -- David Buche, Vice President and Chief Operating Officer, Synovis Surgical Innovations; Mike Campbell,...

</description><pubDate>3/7/2008 7:05:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Synovis Life Technologies, Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Synovis Life Technologies, Inc. Shareholders Meeting Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYNO</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">3:45pm CT</ccbn:time><title>Synovis Life Technologies, Inc. Shareholders Meeting Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1785168</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1762021</link><guid isPermaLink="false">ccbn/T1762021</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good day, ladies and gentlemen, and welcome to the first-quarter #### Synovis Life Technologies, Inc. earnings conference call. My name is Sharon and I will be your coordinator for today. At this time, all participants are in a listen-only mode. We will be facilitating a question-and-answer session towards the end of this conference. (OPERATOR INSTRUCTIONS). As a reminder, this conference is being recorded for replay purposes. I would now like to turn the presentation over to your first host for today's call, Mr. Richard Kramp. He is the President and CEO of Synovis Technologies. Please proceed. ...

</description><pubDate>2/27/2008 1:06:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Synovis Life Technologies, Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q1 2008 Synovis Life Technologies, Inc. Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYNO</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">10:00am CT</ccbn:time><title>Q1 2008 Synovis Life Technologies, Inc. Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1762021</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1735676</link><guid isPermaLink="false">ccbn/T1735676</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>1/8/2008 1:05:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Synovis Life Technologies, Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Synovis Life Technologies, Inc. Conference Call to Discuss Sale of Interventional Business Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYNO</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">10:00am ET</ccbn:time><title>Synovis Life Technologies, Inc. Conference Call to Discuss Sale of Interventional Business Transcript</title><description>...Good day, ladies and gentlemen and welcome to the sale of Interventional conference call. My name is [Jahida] and I will be your coordinator for today. (OPERATOR INSTRUCTIONS). As a reminder, this conference is being recorded for replay purposes. I would like to introduce Mr. Richard Kramp, President and CEO. Please proceed. ...

</description><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1735676</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1695064</link><guid isPermaLink="false">ccbn/T1695064</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>12/31/2007 5:21:18 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Synovis Life Technologies, Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q4 2007 Synovis Life Technologies, Inc. Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYNO</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">10:00am CT</ccbn:time><title>Q4 2007 Synovis Life Technologies, Inc. Earnings Conference Call Transcript</title><description>...Good day, ladies and gentlemen, and welcome to the Synovis Life Technologies fourth quarter #### conference call. At this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session towards the end of today's conference. (OPERATOR INSTRUCTIONS). As a reminder, this conference call is being recorded for replay purposes. I will now turn the presentation over to Mr. Richard Kramp, President and CEO of Synovis Life Technologies. Please proceed, sir. ...

</description><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1695064</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/srp/19806</link><guid isPermaLink="false">srp/19806</guid><srp:index_mode xmlns:srp="http://www.alacra.com/srp">norm</srp:index_mode><description>...Address:#### University Avenue West, St. Paul, Minnesota #####-#### Incorporated:MinnesotaWeb Site: www.synovislife.comSIC Classification: Orthopedic, Prosthetic, and Surgical Appliances and Supplies (####) Business Description: Synovis Life Technologies, Inc. is a diversified medical device company engaged in developing, manufacturing and bringing to market products for the surgical and interventional treatment of disease. Indices:Russell ####, Russell #### ...

</description><srp:company xmlns:srp="http://www.alacra.com/srp">19806</srp:company><title>Synovis Life Technologies, Inc.</title><srp:cusip xmlns:srp="http://www.alacra.com/srp">87162G105</srp:cusip><srp:ticker xmlns:srp="http://www.alacra.com/srp">SYNO</srp:ticker><pubDate>10/15/2007 6:39:00 AM</pubDate><srp:docid xmlns:srp="http://www.alacra.com/srp">19806</srp:docid><category>Credit &amp; Investment Research</category><alacra:ip>SharkRepellent.net</alacra:ip></item></channel></rss>